loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2005_182___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Servier

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ORIL INDUSTRIE Bolbec FR (1)

    filter

    01 Gliclazide (1)

    filter

    01 France (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ORIL INDUSTRIE Bolbec FR

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Gliclazide

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2005-182 - Rev 01
    Valid
    Chemical
    2020-02-28
    1524
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2005-182 - Rev 01 of Oril Industrie Bolbec Fr

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2005-182 - Rev 01 of Oril Industrie Bolbec Fr 1

    20

    Oril Industrie Bolbec Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Gliclazide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2005-182 - Rev 01

    This Chemical Type CEP, issued on February 28, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1524 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY